Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer
靶向癌相关成纤维细胞驱动的LIF/LIFR轴可提高吉西他滨和白蛋白紫杉醇在胰腺癌中的治疗效果
期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01046-w
Bhatia, Rakesh; Khan, Imran; Li, Xiaoqi; Gautam, Shailendra; Seshacharyulu, Parthasarathy; Alsafwani, Zahraa Wajih; Bhyravbhatla, Namita; Ponnusamy, Moorthy P; Jain, Maneesh; Malafa, Mokenge; Bindu, Santhamma; Gulzar, Ahmed; Nair, Hareesh; Batra, Surinder K; Kumar, Sushil
胰腺癌
LIF
LIFR
肿瘤
成纤维细胞
细胞生物学
肿瘤免疫